Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **heme detoxification pathway in Plasmodium falciparum** is a critical metabolic route the malaria parasite uses to neutralize toxic free heme released during hemoglobin digestion inside infected red blood cells. Free heme, released as hemoglobin is broken down in the digestive vacuole, is highly cytotoxic due to its redox activity. To survive, the parasite converts this free heme into an insoluble crystalline form called hemozoin, a process facilitated primarily by enzymes such as falcipain 2 protease and the heme detoxification protein (HDP), and potentially lipid catalysis. Disruption of this pathway, particularly the inhibition of hemozoin formation, is the mode of action of several frontline antimalarials, including chloroquine, quinine, and artemisinin. These drugs prevent the detoxification of heme by interfering with its crystallization, leading to the accumulation of toxic heme and death of the parasite. The pathway is considered the "weakest link" in the parasite's lifecycle, making it a prime drug target in malaria treatment. Because the process and resulting hemozoin are unique to Plasmodium species, this pathway is highly selective as a therapeutic target, but the emergence of resistant parasite strains poses a growing challenge.
Inhibition of hemozoin (malarial pigment) crystallization Complexing with free heme to prevent detoxification Interfering with hemoglobin digestion enzymes
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme detoxification pathway in Plasmodium falciparum.